211 related articles for article (PubMed ID: 11850837)
1. p60(v-src) and serum control cell shape and apoptosis via distinct pathways in quail neuroretina cells.
Aouacheria A; Ory S; Schmitt JR; Rigal D; Jurdic P; Gillet G
Oncogene; 2002 Feb; 21(8):1171-86. PubMed ID: 11850837
[TBL] [Abstract][Full Text] [Related]
2. Distinct protease pathways control cell shape and apoptosis in v-src-transformed quail neuroretina cells.
Néel BD; Aouacheria A; Nouvion AL; Ronot X; Gillet G
Exp Cell Res; 2005 Nov; 311(1):106-16. PubMed ID: 16202997
[TBL] [Abstract][Full Text] [Related]
3. Stable expression of intracellular Notch suppresses v-Src-induced transformation in avian neural cells.
Mateos S; Amarir S; Laugier D; Marx M; Calothy G
Oncogene; 2007 May; 26(23):3338-51. PubMed ID: 17146440
[TBL] [Abstract][Full Text] [Related]
4. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
Lin X; Gelman IH
Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
[TBL] [Abstract][Full Text] [Related]
5. Serum factors and v-src control two complementary mitogenic pathways in quail neuroretinal cells in culture.
Gillet G; Michel D; Crisanti P; Guérin M; Herault Y; Pessac B; Calothy G; Brun G; Volovitch M
Oncogene; 1993 Mar; 8(3):565-74. PubMed ID: 8437841
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel quiescence responsive element downregulated by v-Src in the promoter of the neuroretina specific QR1 gene.
Provot S; Pouponnot C; Lecoq O; Calothy G; Felder-Schmittbuhl MP
Oncogene; 2000 Sep; 19(41):4736-45. PubMed ID: 11032024
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic protein p60v-src has competence activity but does not activate phosphatidylinositol turnover or protein kinase C in Balb/c 3T3 cells.
Han JW; Gaut J; Burstein E; Sadowski H; Young D; Macara IG
Oncogene; 1990 Apr; 5(4):467-74. PubMed ID: 2158036
[TBL] [Abstract][Full Text] [Related]
8. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein.
Wyke AW; Frame MC; Gillespie DA; Chudleigh A; Wyke JA
Cell Growth Differ; 1995 Oct; 6(10):1225-34. PubMed ID: 8845299
[TBL] [Abstract][Full Text] [Related]
9. The product of the v-src-inducible gene nr-13 is a potent anti-apoptotic factor.
Mangeney M; Schmitt JR; Leverrier Y; Thomas J; Marvel J; Brun G; Gillet G
Oncogene; 1996 Oct; 13(7):1441-6. PubMed ID: 8875982
[TBL] [Abstract][Full Text] [Related]
10. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
Wu SJ; Ng LT; Lin CC
Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
[TBL] [Abstract][Full Text] [Related]
11. Partial characterization of the mitogenic action of pp60v-src, the oncogenic protein product of the src gene of avian sarcoma virus.
Durkin JP; Whitfield JF
J Cell Physiol; 1984 Aug; 120(2):135-45. PubMed ID: 6086674
[TBL] [Abstract][Full Text] [Related]
12. Proliferation of chicken neuroretina cells induced by v-src, in vitro, depends on activation of the E2F transcription factor.
Pasteau S; Loiseau L; Brun G
Oncogene; 1997 Jul; 15(1):17-28. PubMed ID: 9233774
[TBL] [Abstract][Full Text] [Related]
13. Cell division is required for expression of v-myc transforming properties in chicken embryonic neuroretina cells.
Bechade C; Calothy G
Oncogene; 1991 Dec; 6(12):2311-7. PubMed ID: 1662792
[TBL] [Abstract][Full Text] [Related]
14. Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele.
Bader AG; Hartl M; Bister K
Virology; 2000 Apr; 270(1):98-110. PubMed ID: 10772983
[TBL] [Abstract][Full Text] [Related]
15. High K+ and IGF-1 protect cerebellar granule neurons via distinct signaling pathways.
Zhong J; Deng J; Huang S; Yang X; Lee WH
J Neurosci Res; 2004 Mar; 75(6):794-806. PubMed ID: 14994340
[TBL] [Abstract][Full Text] [Related]
16. Effect of orthovanadate on commitment of avian myoblasts transformed with Rous sarcoma virus to myogenic differentiation.
Hase H; Isobe A; Kim J
Eur J Cell Biol; 1995 Nov; 68(3):313-22. PubMed ID: 8603684
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
18. Delineating v-Src downstream effector pathways in transformed myoblasts.
Ciuffini L; Castellani L; Salvati E; Galletti S; Falcone G; Alemà S
Oncogene; 2008 Jan; 27(4):528-39. PubMed ID: 17637741
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
20. Increased activity of c-Src and Csk in fibroblasts transformed by v-src oncogene.
Tuhácková Z; Vojtechová M; Hlavácek J; Ruzzene M; Sovová V; Pinna LA
Biochem Biophys Res Commun; 2002 Jan; 290(2):790-5. PubMed ID: 11785970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
